Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07079306 · ClinicalTrials.gov registry record · NA
ChatGPT-Supported Text Messaging Program for Smoking Cessation
A NA study, sponsored by George Washington University.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07079306: Clinical Trial NA study, sponsored by George Washington University.
NCT07079306 is a NA study that has not yet begun recruiting, run by George Washington University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07079306, a NA study, has not yet begun recruiting, sponsored by George Washington University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Primary Outcome
the longest continuous period (in days) that you did not smoke a cigarette
Interventions
- BEHAVIORAL BeFree+Bot
- BEHAVIORAL BeFree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
What is known before NCT07079306 opens enrollment
NCT07079306 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which BeFree+Bot is the first listed.
NCT07079306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07079306 about?
NCT07079306 is a clinical study titled "ChatGPT-Supported Text Messaging Program for Smoking Cessation". The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and B...
What is the current status of trial NCT07079306?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-10-01. Estimated completion is 2027-01-30.
What interventions are being tested in trial NCT07079306?
The interventions under investigation include: BeFree+Bot (BEHAVIORAL), BeFree (BEHAVIORAL).
Who is sponsoring clinical trial NCT07079306?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07079306's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI